We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » London Appeals Court Says Lyrica Generics Do Not Infringe Pfizer’s Pain Patent
London Appeals Court Says Lyrica Generics Do Not Infringe Pfizer’s Pain Patent
The UK Court of Appeal affirmed an earlier ruling that invalidates Pfizer’s patent claims for Lyrica, saying generic versions will not lead to any infringement.